Tuberculosis

Is treatment of tuberculosis in Malawi prolonging the lives of people with HIV/AIDS?

Over the last 15 years, tuberculosis (TB) case numbers have increased 300-400% in Malawi, in conjunction with a rise in HIV infection. This is primarily because HIV increases the risk of disease reactivation in people with latent tuberculosis infection, and also because it increases susceptibility to new TB infections.

Technology reminds sick to take pills

CAPE TOWN A local doctor has developed a pill bottle that uses cellphone technology to remind patients to take their medicines and warns them if they are about to take an extra dose by mistake.

The Voice of the People

According to the citizens of Africa, Latin America and West Asia, HIV/Aids is the most important disease in these regions but it is seen as the second most important disease overall by citizens of the world. This was the most important finding in a survey released worldwide today by Gallup International, and their South African associate, Markinor.

World Report on Knowledge for Better Health

Published by: 
World Health Organization
The Report focuses on bridging of the know do gap, the gulf between what we know and what we do in practice, between scientific potential and health realization. The bridging of this gap is central to achieving the health-related Millennium Development Goals (MDGs) by 2015. The gap exists for each of the MDGs and represents a fundamental and pragmatic knowledge translation challenge that must be addressed to strengthen health systems performance towards achieving the MDGs. The Report will expound the message that we must turn scientific knowledge into actions, which improves peoples health, and that health improvement through knowledge applications is a critical factor in human development and alleviation of ill-health and poverty worldwide. The Report will be highlighted at the World Ministerial Summit on Health Research in Mexico (November 16-20, 2004).

Scaling up AIDS treatment in Africa: issues and challenges

Background paper for The Commission on HIV/AIDS and Governance in Africa Interactive. Gaborone, Botswana 26-27 July 2004 Until recently, life-prolonging treatment was available only to a tiny fraction of HIV-positive people in Africa. High costs, a demanding treatment regime and the lack of even a basic health infrastructure to deliver the treatment were cited as insurmountable barriers to providing treatment to Africans who needed it. Over the last two to three years, this perception has gradually changed. Four interrelated developments have helped to change this perception:

TB treatment: four month continuation phase better than six months

The publication of an international study shows that six months of continuation phase treatment with isoniazid and ethambutol results in higher rates of relapse after treatment when compared to a four month continuation phase using isoniazid and rifampicin. The International Union Against Tuberculosis and Lung Disease and the United Kingdom Medical Research Council designed the study.